181
Participants
Start Date
January 31, 2005
Primary Completion Date
October 31, 2007
Study Completion Date
November 30, 2007
Lenalidomide (CC-5013)
Lenalidomide 2-5 mg capsules taken one time per day
North Shore University Hospital, Bethpage
University of Rochester Medical CenterPain Services, Rochester
Drexel University College of MedicineDepartment of Neurology Rm 7102, Philadelphia
Johns Hopkins Pain Center, Baltimore
University of Virginia Pain Management Center, Charlottesville
Carolinas Pain Institute, P.A. & the Center for Clinical Research, LLC, Winston-Salem
Duke University Medical Center, Durham
Emory University Hospital, Atlanta
Space Coast Neurology, Palm Bay
Gold Coast Research, LLC, Weston
Research Institute of Greater Dayton, Dayton
University of Iowa, Iowa City
Mayo Clinic, Rochester
Rehab Institute of Chicago, Chicago
Washington University Pain Mgmt Ctr, St Louis
KRK Medical Research, Richardson
Texas Tech Medical Center Department of Anesthesiology, Lubbock
Arizona Research Center, Phoenix
Genova Clinical Research, Inc, Tucson
Loma Linda Institution, Loma Linda
Swedish Pain Services, Seattle
Attn: Maryjane CerroneLehigh Valley Hospital, Allentown
Fletcher Allen Healthcare for Pain Medicine, South Burlington
Lead Sponsor
Celgene Corporation
INDUSTRY